InventionMed S.A. focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology.
Excellent balance sheet with weak fundamentals.
Share Price & News
How has InventionMed's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: INM's share price has been volatile over the past 3 months.
7 Day Return
PL Medical Equipment
1 Year Return
PL Medical Equipment
Return vs Industry: INM underperformed the Polish Medical Equipment industry which returned 93.5% over the past year.
Return vs Market: INM exceeded the Polish Market which returned -18.7% over the past year.
Price Volatility Vs. Market
How volatile is InventionMed's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StInventionMed (WSE:INM) Is In A Strong Position To Grow Its Business
1 month ago | Simply Wall StWhat Kind Of Shareholder Appears On The InventionMed S.A.'s (WSE:INM) Shareholder Register?
3 months ago | Simply Wall StThe InventionMed (WSE:INM) Share Price Has Gained 115%, So Why Not Pay It Some Attention?
Is InventionMed undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate INM's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate INM's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: INM is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: INM is unprofitable, so we can't compare its PE Ratio to the Polish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate INM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: INM is overvalued based on its PB Ratio (6x) compared to the PL Medical Equipment industry average (3x).
How is InventionMed forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as InventionMed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine InventionMed's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- InventionMed competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has InventionMed performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: INM is currently unprofitable.
Growing Profit Margin: INM is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: INM is unprofitable, but has reduced losses over the past 5 years at a rate of 47% per year.
Accelerating Growth: Unable to compare INM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.7%).
Return on Equity
High ROE: INM has a negative Return on Equity (-5.82%), as it is currently unprofitable.
How is InventionMed's financial position?
Financial Position Analysis
Short Term Liabilities: INM's short term assets (PLN146.8K) do not cover its short term liabilities (PLN354.2K).
Long Term Liabilities: INM's short term assets (PLN146.8K) exceed its long term liabilities (PLN1.4K).
Debt to Equity History and Analysis
Debt Level: INM is debt free.
Reducing Debt: INM has no debt compared to 5 years ago when its debt to equity ratio was 21.6%.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: INM has sufficient cash runway for 1.9 years if free cash flow continues to grow at historical rates of 5.6% each year.
What is InventionMed's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate INM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if INM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of INM's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.
How experienced are the management team and are they aligned to shareholders interests?
Mr. Tomasz Kierul serves as the Chief Executive Officer and President of Management Board at Inventionmed SA.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
InventionMed S.A.'s company bio, employee growth, exchange listings and data sources
- Name: InventionMed S.A.
- Ticker: INM
- Exchange: WSE
- Founded: 2009
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: zł78.533m
- Shares outstanding: 35.70m
- Website: https://inventionmed.com
- InventionMed S.A.
- ul. Bydgoskich Przemyslowców 6
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|INM||WSE (Warsaw Stock Exchange)||Yes||Common Bearer Shares||PL||PLN||Mar 2013|
InventionMed S.A. focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform essential procedures needed for the treatment of specific skin aliments. InventionMed S.A. was founded in 2009 and is based in Bydgoszcz, Poland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/28 20:18|
|End of Day Share Price||2020/05/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.